endocrine dysfunctions in iron overload in patients with major thalassemia

Authors

a hashemi department of pediatrics, hematology, oncology and genetics research center, shahid sadoughi university of medical scien

z hashemian department of pediatrics, hematology, oncology and genetics research center, shahid sadoughi university of medical scienسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences)

m ordooei pediatric endocrinologist and professor assistant of pediatric department of shahid sadoughi university of medical scien

m amanat medical student, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences)

abstract

abstract background the aim of the present study was to determine the endocrine dysfunction in patients with major thalassemia, who receive hyper transfusion. materials and methods this cross sectional study was performed during one year, which included 65 major thalassemia patients (31 females and 34 males), aged between 14 month to 27 years old (median 10,3). growth assessment was measured by height and weight according to age and bmi. for all patients serum ferrites concentration, serum calcium and phosphorus, alkaline phosphates, fasting blood sugar, thyroid stimulating hormone, free thyroxin, fsh, lh, dehydroepiandrosterone sulfate, testosterone, estradiol were measured. results in this study, 44.9% of patients were found to be shorter than the height of 5th percentile for their age. diabetes mellitus and impaired fasting glucose were seen in 16% and 28.6% of patients respectively. there was significant correlation between serum ferritin level and impaired glucose tolerance test (p-value =0.043) in them. frequency of hypocalcaemia and hyperphosphatemia were 36.9% and 10.7% respectively. frequency of hypogonadism was 54.8%. fourthy percent of the patients had no endocrine abnormalities. conclusion endocrine dysfunctions are extremely frequent in patients with thalassemia, but chelating therapy can prevent or limit these complications. impaired glucose tolerance was one of the most frequent endocrine complications, which were related to ferritin level. key words endocrine system, beta-thalassemia, ferritins

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Endocrine Dysfunctions in Iron Overload in Patients with Major Thalassemia

Abstract Background The aim of the present study was to determine the endocrine dysfunction in patients with major thalassemia, who receive hyper transfusion. Materials and Methods This cross sectional study was performed during one year, which included 65 major thalassemia patients (31 females and 34 males), aged between 14 month to 27 years old (median 10,3). Growth assessment was measur...

full text

Endocrine Disorders in Beta thalassemia Major Patients

Background Thalassemia is the most common hereditary disorder worldwide. The patient's’ survival is dependent on lifetime blood transfusion which leads to iron overload and its toxicity on various organs including endocrine glands. The study aimed to investigate endocrine disorders in patients with Beta-thalassemia major in the Southern Khorasan province, Iran. Materials and Methods In this des...

full text

Endocrine and metabolic disorders in &#946 -thalassemia major patients

Background: Thalassemia is the most common hereditary anemia and beta thalassemia major is its most severe form. Endocrine abnormalities in thalassemia major are common disturbing complications that need prompt management. The purpose of this study was to determine the endocrine disorders and bone mineral density in patients with major -thalassemia in Qazvin, Iran. Methods: In this cross- sect...

full text

Sequential Deferoxamine - Deferasirox in Treatment of Major Thalassemia with Iron Overload

Abstract Background Iron overload is a major problem in patients with major thalassemia. An effective and safe iron chelator protocol with high compliance rate plays an important role in treatment of these patients. This study was done to assess the efficacy and safety of the sequential deferoxamine and deferasirox protocol in major thalassemia patients in Khuzestan province, Iran. Material ...

full text

Myocardial iron overload in thalassemia major. How early to check?

Methods From the 2171 patients enrolled in the MIOT (Myocardial Iron Overload in Thalassemia) network, we retrospectively selected the 35 TM patients aged less than 10 years who had undergone at least one MRI scan. Myocardial iron overload (MIO) was measured by T2* multislice multiecho technique. Biventricular function parameters were quantitatively evaluated in a standard way by cine images. T...

full text

Treatment of cardiac iron overload in thalassemia major.

The inexorable tissue iron accumulation in thalas-semia major is well documented and is fatal unless chelation therapy is given to remove the iron from the tissues. Desferal thus revolutionized the treatment of iron overload in thalassemia and dramatically improved survival. Desferal has been widely available now for over two decades and initially it was thought that life expectancy might be op...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pediatric hematology and oncology

جلد ۲، شماره ۲، صفحات ۶۰-۶۶

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023